To assess the effectiveness of violate oil from Blumea Balsamifera (L.) DC. leaves (BB oil) on wound healing in mice.
INTRODUCTION
Traditional medicine practitioners have described the therapeutic efficacies of many traditional and indigenous plants against diseases. 1 Natural products that are safe, and possess physiological properties are excellent sources of new therapeutics for the treatment of conditions like mechanical damage of the skin. 2, 3 Some researchers therefore have shifted their focus to the potential wound healing properties of plants. 4 Wound healing is a process of restoring damaged cells and tissues. [5] [6] [7] The phases of wound healing occur in a precise and regulated order. Firstly, it involves hemostasis and inflammation; secondly, mesenchymal cells differentiate, proliferate, and migrate to the wound site; thirdly, angiogenesis and epithelial deposition at the wound surface site. Finally, synthesis, cross-linking and alignment of collagen is required to provides structural strength to the wound healing tissue. 8 The wound also undergoes physical contraction, which might be mediated by contractile fibroblasts. 9 Neuropeptide Substance P (SP) is a pro-inflammatory neuropeptide, and modulates inflammatory responses of skin wounds. SP also promotes the synthesis and metabolism of fibroblast and increases accumulation of collagen in the proliferative phase of mesenchymal cell growth and dynamics. 10 In addition, SP is an important medium in the process of wound repair and scar healing. 11, 12 Ainaxiang (Herba Blumeae Balsamiferae), also named Sambong in some tropical countries, is an herb with a rich constitution of essential oils that are used in Traditional Chinese Medicine (TCM). 13 In China, Blumea Balsamifera (L.) DC. normally grows in Hainan and Guizhou. 14, 15 Its leaves have been used for healing many conditions including eczema, dermatitis, skin injury, skin bruises, beriberi, lumbago, menorrhagia, rheumatism, and some other diseases. 16 Recently, the extracts of the leaves have been verified to display physiological activities on plasmin-inhibitory, 17, 18 anti-fungal, 19, 20 free radical scavenging and anti-obesity functions. 21, 22 The Records of Seeking Herbal Medicines in Lingnan, an ancient Chinese medical work, described that the extract from Ainaxiang (Herba Blumeae Balsamiferae), was used to treat snakebite injury, and skin wounds and itch. It documented that external application of the mashed fresh leaves or leaf water washings decoction could treat traumatic injury, carbuncle and skin pruritus. 23 The main active ingredient in the violate oil from Blumea Balsamifera (L.) DC. leaves (BB oil) is l-borneol. However, little systematic study has been found on the pharmacologic use of BB oil. Herein, we have evaluated the potential for, and possible mechanisms of action of, BB oil to promote wound healing.
METERIALS AND METHODS

PLant and its volatile oil preparation
Blumea Balsamifera (L.) DC. was obtained from Luodian, Guizhou, China. It was identified by Dr. Yuxin Pang, associate researcher fellow at the Tropical Crops Genetic Resources Institute, Chinese Academy of Tropical Agricultural Sciences, Danzhou, Hainan, China. The herbarium voucher specimen (TCGRI 10011) was saved. BB oil was obtained by distilling its air-dried leaves with steam at Guizhou Ai-Yuan Ecological Medicine Development Industry, Guizhou, China. A yield of 0.1 mL of BB oil was obtained from each Kg of fresh Blumea Balsamifera (L.) DC. leaves.
Determination of l-borneol content in BB oil
The standard l-borneol (98% , Batch No. 10147015) was produced by Alfa Aesar, Heysham, Lancs, UK. The content of l-borneol of BB oil was determined by gas chromatography (GC, Agilent 7890, Santa Clara, CA, USA), using ethyl acetate as the solvent. The separation was performed on a HP-5 quartz capillary column (30 m × 320 μm, 0.5 μm) equipped with a flame ionization detector (FID) detector. The injection volume was 0.6 μL and was carried out by nitrogen without splitting. The injector temperature was maintained at 250℃ and detector, 280℃ . The oven temperature was programmed from 60℃ for 1 min, raised to 100℃ at a rate of 5℃/min, and to 260℃ at a rate of 20℃/ min, and isotherm at 260℃ for 5 min. The number of theoretical plates was more than 50 000 and the separation degree was greater than 1.5. The external standard method was used. 
Animals
Animal modeling and grouping
Totally 98 mice were randomly divided into seven groups by random number table method: Control (n= 14), solvent control (n=14), basic fibroblast growth factor (BFGF) (n=14), cream of Jing Wan Hong (JWH) (n=14), undiluted violate oil from Ainaxiang leaves (Blumeae Balsamiferae Folium) (BB oil) (n=14), BB oil diluted in olive oil to v/v=1/5 (BB oil1/5) (n=14), and BB oil diluted in olive oil to v/v=1/10 (BB oil1/10) (n=14).
Mouse wound model and drug treatments
Mice were anesthetized in advance by intraperitoneal injection with 5% chloral hydrate (0.1 mL per 10 g). The model skin was depilated with electric clippers. The part of each mouse that was at the back of the front leg, and located along the spine on the right side of the mouse at a distance of 1.0 cm, was perforated with a sterilized puncher. The diameter of the wound was 1.5 cm. Then the wound was trimmed with a scalpel to the depth of the fascia. Hemostasis was carried out with a piece of sterile gauze. By doing these, the mechanically induced wound animal model was formed. 26 Approximately 0.05 mL of the different drug preparations was applied to the wound once daily. Three groups, undiluted BB oil, BB oil1/5 and BB oil1/10, were set up respectively. The BB oil1/5 and BB oil1/10 were BB oil diluted in olive oil to 1/5 and 1/10 (v/v), respectively. There was no drug treatment in the control group, and 0.05 mL olive oil (Shanghai Lingfeng Chemical Reagent Co., Ltd., Shanghai, China, 20120816) was applied in the solvent control group. There were two positive groups. A prepared solution of BFGF (basic fibroblast growth factor, Zhuhai Essex Bio-Pharmaceutical Co., Ltd., Zhuhai, Guangdong, China, No. S10980077) was applied in the BFGF group. The cream of JWH (Jingwanhong, Tianjin Darentang Jingwanhong Pharmaceutical Co., Ltd., Tianjin, China, No. Z12020440) was applied in the JWH group.
Observation of wound healing
The number and relative production of the exudates, contraction, and the scab and skin colors of the wound were observed on days 1, 3, 5, 7 and 10 following treatments.
Wound healing rate determination
On days 1, 3, 5, 7, and 10, the wound healing rate (WHR) was measured by weighs. The wound was covered with transparent film and labeled along the wound edge. Then, the required area was cut off and weighed. The wound healing process was considered to be completed once the WHR reach 95%. 27 WHR (%)=[(Wo-Wu)/Wo]×100 Wo: Original wound area weight; Wu: Unhealed wound area weight.
Histopathological observation
On days 3, 7 and 10, the skin specimens of the wound were cut out and immediately fixed in 10% v/v neutral-formaldehyde for 24 h. The specimens were embedded in paraffin and 4 μm sections were sliced for hematoxylin and eosin (HE) staining (HE staining kit, Nanjing Jiancheng Bioengineering Institute, Nanjing, China, batch No. 20120926). The slices were observed under a microscope for histological evaluation of fibroblast proliferation, angiogenesis, epithelial regeneration, and collagen deposition.
Determination of collagen
On days 3, 7 and 10, the skin specimens were stained by using the Masson staining kit (Nanjing Jiancheng Bioengineering Institute, Nanjing, China, batch No. 20121119) to determine the content of collagen. Ten random views of each slice were observed under microscope (× 40). Then the optical density (OD) and area of each view were assessed by using the software Image-Pro plus 6 to determinate collagen deposition.
Determination of hydroxyproline
On days 3, 7 and 10, the basal skin tissues were cut from the center of the wounds. The determination of hydroxyproline was carried out according to the hydroxyproline alkali hydrolysis kit (Nanjing Jiancheng Bioengineering Institute, Nanjing, China, batch No. 20121023).
Determination of SP
SP content in the wound was determined by using the SABC (Streptavidin-Biotin Complex kit, Wuhan Boster Bioengineering Co., Ltd., Wuhan, China, batch No. 07J16BM). Five random views of each slice were observed under microscopy (× 40). The OD of each view was assessed by using the software program Image-Pro plus 6 to determinate SP content.
Statistical analysis
Results were expressed as mean ± standard deviation (SD) and statistical analysis was performed by using Duncan's New Multiple Range Test. Data analysis was performed by using the software SPSS 21 (SPSS Inc., Chicago, IL, USA). The statistical significance was set at P<0.05.
RESULTS
Content of l-borneol
The GC maps of the standard and samples are shown in Figure 1 . L-borneol showed a good linear relationship under 0.05-0.78 mg/mL. The regression equation was Y=13012X-61.963, with an average recovery of 100.4% and a relative standard deviation (RSD) of 0.93% . The content of l-borneol in BB oil in this study was 22.7%.
Situation of wound healing
All mice grew well and their weights increased steadily. No unusual drinking or urination was observed. The wound tissues in BFGF, JWH, BB oil1/10 and BB oil1/5 groups were ruddy, and arranged in order and no skin scrapings on the edge. On day 2, the new epidermis covered the wound edge, and the inflammatory response yet undetected. Then, the wound of the control mice and solvent control groups were rather black and dry. On day 3, wound edges of some mice were epithelized. However, in the undiluted BB oil groups, the wounded skin was dark and some wounds dehiscence and hemorrhage were observed. After the wound healed, the skin was partially thickened and hardened. Some mice in undiluted BB oil group depilated in a large area, and the depilated skin was dark red.
Wound healing rate
By day 3, the BB oil1/5 and BB oil1/10 groups showed significant high WHRs than control (P<0.05). On days 5 and 7, these two groups healed the wounds significantly. The wounds in the BB oil1/5 and BB oil1/10 groups had achieved more than 60.0% wound contraction. However, the WHR in the undiluted BB oil group were low by day 10 (Table 1) .
Histopathological evaluation
On day 3, inflammatory cells had infiltrated the wound, and a few capillaries had formed. The infiltration with inflammatory cells were light, and new capillaries and fibroblast were significantly more evident following treatments with BFGF, JWH, BB oil1/5 and BB oil1/10 as compared the other treatments. The collagen depositions in these four groups were better. The epidermis in the undiluted BB oil group showed significant thickening, and the fibroblasts were smaller and in a disordered state. The wounds in this group healed much worse than did the other groups (Figure 2 ).
Effects on content of collagen
We evaluated the collagen contents, fibrous proteins and constituent of non-contractile connective tissues, by surveying the OD of the stained blue slide of the wound. 28 On day 3, there were few collagen fibers in the proliferating granulation tissue. The average OD in the BB oil1/5 and BB1/10 groups were 0.303 and 0.322, which were higher than other groups (P<0.01, Table  2 ).
Effects on hydroxyproline content
On day 3, there were statistically significant differences in hydroxyproline content of each treatment group as compared with the control and solvent treatment groups (P<0.01). The contents of hydroxyproline in undiluted BB oil, BB oil1/5 and BB oil1/10 groups were 1.64, 2.00 and 2.30 μg/mL respectively, which were markedly higher than that seen in the control groups with 59.22% , 94.18% and 123.30% , and were 1.76, 2.15, 2.47 times than that seen in the solvent control group. However, on day 10, the hydroxyproline content in BB oil group (2.87 μg/mL) was the lowest ( Table 3 ).
Effect on the content of SP
SP shows the most positive reaction appearing on slice specimens as a yellow-brown coloration. The cells in the negative control group were stained blue without a positive reaction. The average OD represents the con-tent of SP (Table 4 ). On day 3, the average OD of SP in the BB oil group was 0.0212, which was higher than was seen for the other groups, especially in the context of the control and solvent control groups (P<0.01). On day 7, SP in the undiluted BB oil and BB oil1/5 groups increased highly significantly as compared with that seen in the control and solvent control groups (P< 0.01).
DISCUSSION
In the present study, the effect of BB oil was investigated. The major active ingredient of BB oil, l-borneol, induces resuscitation, relieves pain, has an anti-inflammatory effect, activates blood, and inhibits sympathetic nerve conduction. 24, 25, 30 Our findings revealed that BB oil1/5 and BB oil1/10 improved wound contraction and closure, and the effects were extremely and distinctly strong. Histopathological evaluation of the wound provided additional evidence of a more desirable histological organization. Our results revealed that, with the concentrations tested in the study, BB oil improved the formation of collagen and fibroblasts, and reduced the number of inflammatory cells that were required to accelerate effective wound healing and granulation of new tissue in the proliferative phase. The healing process depends on the biosynthesis and deposition of collagens and their maturation. Filling of the wound with granulation tissue serves to heal the wound. The granulation tissue is comprised of fibroblasts, collagen, edematous fluids, and small neovascularized blood vessels. The increase in granular tissue dry weight suggests an increase in proteins. Thus, the healing process depends predominantly on the subsequent maturation of collagen. 31, 32 Collagen is comprised of amino acids (e.g., hydroxyproline), and it is an important component of strengthening and supporting extracellular tissues. Breakdown of collagen liberates free hydroxyproline and peptides. 26, 4, 33 Therefore, the content of hydroxyproline is an index of collagen turnover. 34 In this study, BB oil1/5 and BB oil1/10 demonstrated a significant increase in the hydroxyproline content of the granulated tissue, indicating an increase of collagen turnover. Both these two diluted BB oils stimulated wound healing more potently and more effectively than did the others. These findings implied that BB oil1/5 and BB oil1/10 promoted wound healing by influencing the proliferative and remodeling phases of wound healing, and do so via the pathways of angiogenesis, collagen deposition, granular tissue formation, epithelial deposition, and wound contraction. This result was also relevant in the context of other traditional medicinal plants. Topical applications of many traditional medicinal plants for skin wounds have been proved to have certain positive effects. These findings made these folk herbs potential skin wound healing agents. 29, 35, 36 Peripheral nerves that conduct wounded tissues, also release SP, and then SP participates in the regulation of wound healing. SP plays an important role in communicating the nervous system with the wounded tissues. 37, 38 In this experiment, determination of SP content showed that BB oil, BB oil1/5 and BB oil1/10 markedly promoted the expression of SP in the proliferative phase. The wound healing mechanism, under conditions of optimized concentrations of BB oil might be mediated, at least in part, by an increase in SP secretion. In addition, BB oil1/5 and BB oil1/10 increased the formation of new blood capillaries in the proliferative phase. This result could verify the efficacy of BB oil of its claimed Chinese medical efficacy "it can improve blood circulation and eliminate extravasated blood," and this efficacy might be associated with SP secretion. Moreover, the effect of BB oil1/5 and BB oil1/10 on capillary regeneration, blood circulation and accelerated wound healing might also be due to SP secretion. Possible mechanisms contributing to wound healing might be associated with SP secretion and the proliferation and differentiation of regulated cells. However, the results in the undiluted BB oil group suggest that undiluted BB oil was not an optimum solution for accelerating wound healing. It should be diluted before being used to heal wounds. Further research and critical analysis on this filed is needed. In summary, BB oil1/5 and BB oil1/10 promoted capillary regeneration, blood circulation, collagen deposition, granular tissue formation, epithelial deposition, and wound contraction. The BB oil1/5 and BB oil1/10 tested in this study can promote and enhance wound healing. These results may provide significant evidence for BB oil in clinical practice. 
